Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

National survey for drug-resistant variants in newly diagnosed antiretroviral drug-naive patients with HIV/AIDS in South Korea: 1999-2005.

Journal of acquired immune deficiency syndromes (1999) - 1 Nov 2008

Choi Ju-Yeon, Kim Eun-Jin, Park Yong Keun, Lee Joo-Shil, Kim Sung Soon

Abstract excerpt

We investigated the prevalence of drug-resistant variants and assessed their severity against antiretroviral drugs among patients in South Korea. Three hundred antiretroviral drug-naive patients were collected and drug-resistant variants were analyzed using the Stanford database with sequences and mutation data of the HIV-1 genes for protease (codons 1-99) and reverse transcriptase (codons 1-250). Of this group,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Acquired Immunodeficiency Syndrome
Share to Anti-HIV Agents

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Resistance, Viral

Share to Phylogeny

Share to Reverse Transcriptase Polymerase Chain Reaction

Share to Time Factors

Source

Identifiers

PMID: 18845957
DOI: 10.1097/QAI.0b013e318188a919

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

National survey for drug-resistant variants in newly diagnosed antiretroviral drug-naive patients with HIV/AIDS in South Korea: 1999-2005.PMID 18845957Read ↗

HIV antiretroviral resistance mutations among antiretroviral treatment-naive and -experienced patients in South Korea.Semantic proximity Read ↗

Drug susceptibility of human immunodeficiency virus type 1-derived pseudoviruses from treatment-experienced patients to protease inhibitors and reverse transcriptase inhibitors, using a modified single-round assay.Semantic proximity Read ↗

Prevalence and trends in human immunodeficiency virus-1 subtypes and drug resistance in South Korea: Analysis of 5 years’ data (2017‒2022)Semantic proximity Read ↗

HIV-1 Drug Resistance Mutations among Antiretroviral Drug-Experienced Patients in the South of IranSemantic proximity Read ↗

Low prevalence of drug-resistant HIV-1 in patients newly diagnosed with early stage of HIV infection in Korea.Semantic proximity Read ↗

Drug susceptibility to etravirine and darunavir among Human Immunodeficiency Virus Type 1-derived pseudoviruses in treatment-experienced patients with HIV/AIDS in South Korea.Semantic proximity Read ↗

Prevalence of acquired drug resistance mutations in antiretroviral- experiencing subjects from 2012 to 2017 in Hunan Province of central South China.Semantic proximity Read ↗

Genotypic resistance of antiretroviral drugs among drug-naive HIV type 1 patients with the background of long-term access-easy zidovudine therapy.Semantic proximity Read ↗

Patterns of HIV-1 Drug-Resistance Mutations among Patients Failing First-Line Antiretroviral Treatment in South India.Semantic proximity Read ↗

HIV-1 reverse transcriptase and protease mutations for drug-resistance detection among treatment-experienced and naïve HIV-infected individuals.Semantic proximity Read ↗

Assessing subtype and drug-resistance-associated mutations among antiretroviral-treated HIV-infected patients.Semantic proximity Read ↗

The First Characterization of HIV-1 Subtypes and Drug Resistance Mutations among Antiretrovirally Treated Patients in Kermanshah, Iran.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.